Rankings
▼
Calendar
VTRS
Viatris Inc.
$16B
Q4 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.2B
-0.9% YoY
Gross Profit
$1.3B
40.0% margin
Operating Income
$421M
13.0% margin
Net Income
$244M
7.5% margin
EPS (Diluted)
$0.46
QoQ Revenue Growth
+8.4%
Cash Flow
Operating Cash Flow
$496M
Free Cash Flow
$376M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$35.8B
Total Liabilities
$22.5B
Stockholders' Equity
$13.3B
Cash & Equivalents
$292M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.2B
$3.3B
-0.9%
Gross Profit
$1.3B
$1.3B
-3.0%
Operating Income
$421M
$316M
+33.2%
Net Income
$244M
$418M
-41.5%
← FY 2017
All Quarters
Q1 2018 →
VTRS Q4 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena